Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-09-30 to 2025-09-29
Current total value of award: $13877673.75
Description: PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))